Philip Morris
the Limiting Factors in Understanding the Natural History of Tobacco Smoke Effects in the Lung
Fields
- Author
- Battigelli, M.C.
- Document File
- 1005052694/1005053222/Carton C17f
- Area
- LEGAL DEPT/CARLSTADT QRSA
- Type
- PSCI, SCIENTIFIC PUBLICATION
- BIBL, BIBLIOGRAPHY
- Litigation
- Stmn/Produced
- Site
- N28
- Master ID
- 1005052801/3146
Related Documents:- 1005052801-3146 Background Material for Working Meeting: Research Needs on Low-Yield Cigarettes 800609-800611
- 1005052805
- 1005052806-2824 Biomedical Abstracts
- 1005052825-2840 Chemistry,Pharmacology and Toxicology Abstracts
- 1005052841-2856 Behavioral Abstracts
- 1005052857
- 1005052858
- 1005052859-2870 'tar' and Nicotine Content of Cigarette Smoke in Relation to Death Rates
- 1005052871-2882 Some Recent Findings Concerning Cigarette Smoking
- 1005052883
- 1005052884-2888 Toward Less Hazardous Cigarettes
- 1005052889-2890
- 1005052891-2900 Less Harmful Ways of Smoking
- 1005052901
- 1005052902-2907 Heart Rate and Carbon Monoxide Level After Smoking High-, Low-, and Non-Nicotine Cigabettes A Study in Male Patients with Angina Pectoris
- 1005052908-2921 Smoking, Carbon Monoxide and Arterial Disease
- 1005052922-2925 Clinical Investigations Hemodynamic Effects of Smoking Cigarettes of High and Low Nicotine Content
- 1005052926-2929 Effect of Non-Nicotine Cigarettes and Carbon Monoxide on Angina
- 1005052930-2933 Comparsion of Increases in Carboxyhaemoglobin After Smoking 'extra - Mild' and 'non - Mild' Cigarettes
- 1005052934-2946 Significance of Nicotine, Carbon Monoxide and Other Smoke Components in the Deyelopment of Cardiovascular Disease
- 1005052947
- 1005052948-2955 the Epidemiology of Lung Cancer Recent Trends
- 1005052956-2961 Effects of Smoking Modified Cigarettes on Respiratory Symptoms and Ventilatory Capacity
- 1005052962-2967 Changes in Bronchial Epithelium in Relation to Cigarette Smoking, 550000-600000 Vs. 700000-770000
- 1005052968-2970 Obsterical and Gynecological Survey Cigarette Smoking and Fetal Breathing Movements
- 1005052971
- 1005052972
- 1005052973-2987 19. Is Tobacco Smoking A Form of Nicotine Dependence?
- 1005052988-3012 14. The Analysis of Smoking Parameters: Inhalation and Absorption of Tobacco Smoke in Studies of Human Smoking Behaviour
- 1005053013 Section 6
- 1005053014-3035 17. Pharmacological and Psychological Determinants of Smoking
- 1005053036-3038 Changes in the Cigarette Consumption of Smokers in Relation to Changes in Tar/Nicotine Content of Cigarettes Smoked
- 1005053039-3048 Proceedings of the Tobacco and Health Conference
- 1005053049-3072 Cigarette Smoking As A Dependence Process
- 1005053073-3076 Pharmacological and Psychological Determinants of Smoking.
- 1005053077
- 1005053078-3091 Selective Reduction of Tumorgenicity of Tobacco Smoke. 11. Experimental Approaches
- 1005053092
- 1005053093
- 1005053098-3102 Carbon Monoxide As A Contributor to the Health Hazards of Cigarette Smoking
- 1005053103-3113 Smoking and Cardiovascular Diseases
- 1005053114-3120 Carcinogens, Cocarcinogens, and Tumor Inhibitors in Cigarette Smoke Condensate
- 1005053121-3133 Chemical Composition of Cigarette Smoke
- 1005053134-3145 the Case for Medium - Nicotine, Low - Tar, Low - Carbon Monoxide Cigarettes
- 1005053146
- Named Person
- Bates
- Thurlbeck
- Wynder
- Thurlbeck
- Request
- Stmn/R1-048
- Stmn/R1-059
- Stmn/R1-060
- Stmn/R1-071
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R1-091
- Stmn/R1-092
- Stmn/R1-059
- Author (Organization)
- Univ of NC
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- okx28e00
Document Images
The Limiting Factors , .
in Understanding the iVatura[ History J"
of Tobacco SrnoiCe i:rfects
y ,
l r
~J .
4
in the Lung
MARIO C: BAT7IIGELL!
©iNision of'Pufmonary! Medicine
University of North Carolirlta
'
Chapel H(ill, North Carolina 27514
The function of' the respiratory apparatus ultimately consists of matching a
certain ventiltttory tlow to a corTeaponding flow of blood at the alveolar
membrane: The deceptive simpiicity of these elements of respiratory physioi-
ogy hardly betrays the vast array of the pathological factors toward which the
respiratory apparatus is vulrnerable and that eventually lead to respiratory im-
pairrttent and failure in an aimost infinite compiexity of steps aad phasp.
Ventilatory disorders, for instance, are tht: direct or mediated consequence of
mechattical deranaements, such as obstructive lesions (tunctional or structurai~
or power failure of either a musculhr or neuroloeical nature-either one the
possible consequencr of pharrnacoio¢ical, infectiouss toxic, oral'ternative ctioll
ogy: Perfusiion chan2es, similarly may derive from a constellhtion of factors~
such as embolic phenomena, infecuous processes, or esrd'iac pump failure or its
inadequacy. Each of these; in turn, mary be the possible consequence of
untoward exposure to noxious factors, cigarette smoke included.
tAlthough ir is convenient to enter a discussion of potential and actual
causes in this context, it is considerably more diflicult to analyze the realistic
events in detail in any Aiven and real ina-tnnce. Often the blz: k box cF the
natural hi'story of respirstory diseases ts very much ti¢htly seaied altd inscruta-
ble. This is particulariy true in the intertnediate and early, phasts ot' the d'asease
process. Our knowledee of pathoiory, although consiidectbl', is discontinuouss
and incomplete, a series of snapshots whenn the facts call for a high-grade movie
sequence: The actual chain of e+unts; going from health to disease, remainss
largcly an unresolved mystery. The transition between health and dise:ues. ;Ls
eloquently commented in a recent paper by Thuribeck (19791, urgently needs
clariftcation througtt structure-function cotrelative studies.
In the particular casc of cigarette-smoke injury of the tripir.ttory function;
the end points are well identifned, but the intermediate steps ure not4 Cellular',
tissue, and organ d:unage are known mostlv in their conclu+ive and' adv;utced
stages, when the reversibility of the injµry is limited or, cis fior the ccue ot'
neoplutic changes laurgely not expectctll For pre+entive intervention, this
1005053094
r

limitation in the knowledge retains a major importance. In term5 of prospective ~:
projections. for instance: the definition of a safe cigarette. the as ailable data are
painftillv inadequate. Missing are the quantitative parameters. the sequence in
chronology of each aberrancy, and the intetaelation between different' and
dkcrete processes making up the whole natural history of the injury. To
establish a dose-effect relationship, a much needed step in modeling tox-
icolo¢icall vrocesses, these dimensions must be secured for each exposure '
modalitv. and for each chemical or combinationi ofi'chemicals and suspected
agcnts, or. in other words, for each dose characteristic. If correctioni must be ai
attempted~ the very process causing injury needs to be better identitied in
details of natural history. with adequate rneasurements obtained along, a time
~
sequence. Otherwise the only option available for prevention would' be un- wj-'
selected and total, abolition of tobacco use, a solution ideally jusritied but ;:~
realistically impractical.
The appropriate questions. then, are: Do we know the morphological
details of cigarette smoke inhalation to a degree adequate to formulate .apro-
priate standards of' use or safety?' Do we know the relationships linking the ,; :~ ;
charrcteristics of exposure (i.e., dose) i to the relevant morphological' and funa
tional aspects of effect in relation to their specific features of reversible and
irreversible outcome? Do we know this, with accuracy sufficient to extrapolate
elements of guidance usefull in engineering a, safe product''' We speak of
emphysema, of chronic bronchitis, of obstructive respiratory Iesions, of neo- ,.;
plastic effects, often neglecting that these are the far advanced results of a
process that has progressed usually for years and, often for decades. These
advanced results have destroyed details of cytological physiology and their f ne .
morphological cotrelates, which at earlier times must have characterized the
progress of injury. The search tor eari!v aspects of this history has traditionally
concluded in the identification of the following five separate phases (Bates
1979) in the natural history of chronic airways disorders:
1. hypertrophy of mucous glands in large ainvays:
2. alteration of physical' properties of the lung;
3, morphological changes of small airways;
4. early loss of alveoli:
5. regional nonuniformity of these changes leading to altered ventilation-'
perfusion relationship.
Some of the difficulties inherent to these studies are:
1. longitudinal morphological studies of human tissue;
2. tetli,tic animal modcls for chronic disease:
3, correlative studies of structure and function.
Recenr views have been voiced against this sequence, questioning, for
instance the hypcrsccretoty phase as an obligatory step in this pathological
.L 0'IJ5QP if-~!V~S

U
Clmitiny Factors of Tobaew Smok*J166
sequence, even deeper doubts are shadowing an elementary understanding; of
the problem of neoplssia. lndeed; to be speciffc. the question of independent
carcinogenicity of the major individual constituents of tobacco smoke, in the J*~--~
actual context of'human exposure. remains larcely conjecturat. 71
Not the least of the concern in this context of complexity is offered by the
wide constellation of putati*.e or real (and proven) respiratory effects in re Psponse to tobacco
smoke, which are listed here without any attempt to rank
them in importance or chronological order a°;
{r
,~1
~
{
~
~,I
I
1. reflexes. { T:
,.
2. secnetions,
3. smooth muscle activation,
4. surface chantes.
5. permeability effects.
6: chemotaxis,
7: immune mechanism.
8'. hyperrtrophy,
9. metapiasia.
10. proliferation.
.
Having reco¢nized the varietyy of consequences resulting from exposure
and having identifed the main agents participating in this exposure, we are left
still with disturbiit, ;aps in knowledge. The main variables that are recognized .; .; ;.. .-!
to influence andicontrol toxicolbgical effects are: .
l. nature:of agent.
2. effectiive~quantity (intensity and!dttration)..
' 3. nature of actions,
4. host factors (susceptibilicy, etc:). , ~
The details of information on this matter can be oni. sunnised. perhaps on aa
qualitative base. without much data for their respective quantitative values.
1'n summary, it is prudent to conclude that the problem waits to be better
defined in its constituent detailk betore its solution can oeaccomplished. Unless
the details are known in their temporal' and dosimetric characteristics (which
chemical, which process, which locuswhich tiine, etc.): the black bux will not i
offer wide avenues of remedy and correction.~A vigorous programof research.
:
coordinated in scope and pursued with, the support of funding commensurate
~
with the magnitude of the task in quesoion, still awaits conception and' im
plementatimn. It is consoling to realize that the solution ot`the cigarette smoking
toxicolbgy will represent a milestone in pulmonary medicine, well beyond the
immediate saving of lives and health.
For the moment, the question posed by the definition of a safer tobacco
product may be rcasonably answered with the~st:ucmznt advocating combustion
that generates less g,ueous products and less particulates. In plain words, the
dose must be sltL,hed.
1005053096

681 M.C. Batdgali
.
REFERENCES Bates. D.W:. 1979. Chronic brunehitis. and emphysema: The search for their natural
history, In~ The Lrne in the tranritirn benaeen IJealthi and disease (eds. P.T.
Macklem and'S_ Permutt). voi, 12. Marcel DcU:er Inc.. New York.
Fletcher. C.M: and R. Peto. 1'976. The natural history of chronic airtlow obstruction.
Brdl. Lrtt. Union Tuberc. S3:78!
Thuribeck. W.:W. 1979. Changes in lung structure. In The Lung in the transition
benruen hea/th und'disru.re teds: P.T. \4acklem and S. Permuttu h+tarcel' Dektcer
Inc.. New York. : , _
CIOMMEMTS.
s
w'YNDER: The end& point in chronic obstructive pulmonary, diseass (COPDI.
in terms of a less: harmful cigarette is far more difficult to measure a'tan~
the end, point of 1un; cancer and' myor.irdial infarction. I wonder whether
you~ ebuld! comment' on this from an epidemiologic standpoint: that is,
wharwould be~the first endpoint that you would be lookins for in a study
of COPD? ~
BATTtGEL1:1: Probably a singlie indicator of incipient effect does not exist. It
is more likely a choire of several indicators that would be used: simulta,
neously andl changed as new data become available. 'Ihe tests eurrentlv
accepted for small airways, such as the tlow rates at lower luns volumes
and the middle -maximal expiratory rates, are currently considered the
most sensitive indicators. Of coursz, clinical subjective evidence of ab-
norm'al'. airways (cough. sputum, etc.) and the mea.surement of diffusion
function may be additional irldices, encompassing,emphysematous change
in addition ttD bronchitis. _
However, these are coarse indicators, limited to the effects of cigarette
smoke on the airways quite independently of'any effect caused on other
systems (i.e. cardiovascular system). and in fact witnout much~ direct
correlation with the neopiastic effects on respiratory, ttissues
